{
  "ticker": "LLY",
  "target_date": "2025-03-25",
  "actual_date": "2025-03-25",
  "collected_at": "2025-12-08T11:33:33.069874",
  "price": {
    "open": 864.6,
    "high": 869.94,
    "low": 843.09,
    "close": 847.49755859375,
    "volume": 2670600,
    "change_1d_pct": -1.45,
    "change_7d_pct": 4.78,
    "change_30d_pct": -1.73
  },
  "technicals": {
    "rsi_14": 32.28,
    "sma_20": 858.39,
    "sma_50": 833.45,
    "macd": -3.634,
    "macd_signal": -2.258,
    "macd_histogram": -1.376,
    "bb_upper": 946.17,
    "bb_lower": 770.61,
    "price_vs_sma20_pct": -1.27,
    "price_vs_sma50_pct": 1.69,
    "volume_ratio": 0.73
  },
  "fundamentals": {
    "market_cap": 888720326656,
    "pe_ratio": 48.572758,
    "forward_pe": 43.74978,
    "price_to_book": 37.32568,
    "price_to_sales": 14.956636,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.85,
    "pct_from_52w_low": 58.93
  },
  "macro": {
    "spy": {
      "price": 572.18,
      "change_1d_pct": 0.24,
      "change_7d_pct": 1.77
    },
    "vix": {
      "level": 17.15,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.31
    },
    "dollar_index": {
      "level": 104.18
    },
    "gold": {
      "price": 3023.7
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why",
      "source": "Yahoo",
      "datetime": 1742939115,
      "summary": "Eli Lilly (LLY) closed at $852.35 in the latest trading session, marking a -1.45% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=40a57910db8a84200a44ed9797b5ea0a3fcc621edae9a430904380830726040a"
    },
    {
      "headline": "Tracking Lone Pine Capital Portfolio - Q4 2024 Update",
      "source": "SeekingAlpha",
      "datetime": 1742936366,
      "summary": "Lone Pine Capital's 13F portfolio value increased slightly from $13.41B to $13.47B. Check out the new stakes and significant stake additions to the portfolio.",
      "url": "https://finnhub.io/api/news?id=7b599a8cc87451e8f3c15fbf0e8c8056afc2603d09bb2b497796a664af570470"
    },
    {
      "headline": "Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting",
      "source": "Yahoo",
      "datetime": 1742934900,
      "summary": "Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25 - 30 in Chicago.",
      "url": "https://finnhub.io/api/news?id=473a20ed9eac2cfccf2e015b3a676bd938b51b6f9bc4501699cbc45ef9cda43b"
    },
    {
      "headline": "GLP-1s are driving returns on R&D investments for Big Pharma, report says",
      "source": "Yahoo",
      "datetime": 1742927160,
      "summary": "Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk\u2019s (NVO) popular diabetes drug Ozempic.",
      "url": "https://finnhub.io/api/news?id=886287b88e14d44d8f090a00ca58279cf999ba6245f33e182435699cad6640f8"
    },
    {
      "headline": "Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%",
      "source": "Yahoo",
      "datetime": 1742918640,
      "summary": "NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.",
      "url": "https://finnhub.io/api/news?id=c54bc4c90accbd722a99816e3d4e7a4fc9f5074e0f7a61496455cf89a9d3b579"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742416067.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/xslF345X05/wk-form4_1742416067.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415936.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/xslF345X05/wk-form4_1742415936.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415842.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/xslF345X05/wk-form4_1742415842.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415665.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/xslF345X05/wk-form4_1742415665.xml"
    },
    {
      "form": "4",
      "date": "2025-03-19",
      "description": "xslF345X05/wk-form4_1742415462.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/xslF345X05/wk-form4_1742415462.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}